Virginia Retirement Systems’s Heron Therapeutics HRTX Stock Holding History

Virginia Retirement Systems’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$64K	Hold	11,200	–	–	﹤0.01%	1099
2021 Q4	$102	Buy	11,200 +100	+0.9%	+$1.02K	﹤0.01%	1085
2021 Q3	$119K	Sell	11,100 -8,200	-42%	-$99.8K	﹤0.01%	966
2021 Q2	$300K	Sell	19,300 -1,600	-8%	-$25.5K	﹤0.01%	924
2021 Q1	$339K	Sell	20,900 -6,900	-25%	-$123K	﹤0.01%	968
2020 Q4	$588K	Sell	27,800 -7,800	-22%	-$136K	0.01%	796
2020 Q3	$528K	Buy	35,600 +15,300	+75%	+$239K	0.01%	748
2020 Q2	$299K	Buy	+20,300	New	+$334K	﹤0.01%	953
2019 Q2	–	Sell	-36,100	Closed	-$882K	–	1149
2019 Q1	$882K	Buy	36,100 +800	+2%	+$20.9K	0.01%	720
2018 Q4	$916K	Sell	35,300 -19,500	-36%	-$536K	0.01%	651
2018 Q3	$1.73M	Buy	54,800 +39,500	+258%	+$1.47M	0.02%	507
2018 Q2	$594K	Sell	15,300 -13,400	-47%	-$427K	0.01%	854
2018 Q1	$792K	Buy	28,700 +2,500	+10%	+$56.7K	0.01%	719
2017 Q4	$474K	Buy	+26,200	New	+$427K	0.01%	828
2017 Q2	–	Sell	-30,600	Closed	-$459K	–	1095
2017 Q1	$459K	Buy	+30,600	New	+$424K	0.01%	894

Other funds holding HRTX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Virginia Retirement Systems's HRTX Position: Q1 2022 in Review

Virginia Retirement Systems held its Heron Therapeutics (HRTX) position steady in Q1 2022 at 11,200 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Virginia Retirement Systems first reported a position in HRTX in Q1 2017 and has held it in 15 quarters since. The position peaked at $1.73M in Q3 2018. 186 funds tracked by Wall St. Rank hold HRTX as of Q1 2022.

Virginia Retirement Systems held 11,200 shares of Heron Therapeutics worth $64K as of Q1 2022.
Virginia Retirement Systems left its Heron Therapeutics share count unchanged in Q1 2022.
Heron Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #1099 holding.
Virginia Retirement Systems first reported a position in Heron Therapeutics in Q1 2017 and has held it in 15 quarters since.
Virginia Retirement Systems's Heron Therapeutics position peaked at $1.73M in Q3 2018.
186 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.